Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Operating Leases: 2023-2024

Historic Operating Leases for Fennec Pharmaceuticals (FENC) over the last 1 years, with Dec 2024 value amounting to $2,000.

  • Fennec Pharmaceuticals' Operating Leases changed negligibly% to $2,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2,000 for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q4 2024, Fennec Pharmaceuticals' Operating Leases is $2,000, which was down 71.43% from $7,000 recorded in Q3 2024.
  • Fennec Pharmaceuticals' Operating Leases' 5-year high stood at $17,000 during Q1 2024, with a 5-year trough of $2,000 in Q4 2023.
  • Moreover, its 2-year median value for Operating Leases was $7,000 (2024), whereas its average is $7,833.